July 2019
Volume 60, Issue 9
Free
ARVO Annual Meeting Abstract  |   July 2019
Development of knock in (KI) mouse models of rhodopsin retinitis pigmentosa
Author Affiliations & Notes
  • Kelly Ziaka
    UCL-Institute of Ophthalmology , London, United Kingdom
  • Kwan-Leong Hau
    UCL-Institute of Ophthalmology , London, United Kingdom
  • Dimitra Athanasiou
    UCL-Institute of Ophthalmology , London, United Kingdom
  • Rosellina Guarascio
    UCL-Institute of Ophthalmology , London, United Kingdom
  • Mònica Aguilà
    UCL-Institute of Ophthalmology , London, United Kingdom
  • James Bellingham
    UCL-Institute of Ophthalmology , London, United Kingdom
  • Smriti A. Agrawal
    Baylor College of Medicine One Baylor Plaza, Texas, United States
  • Yumei Li
    Baylor College of Medicine One Baylor Plaza, Texas, United States
  • Rui Chen
    Baylor College of Medicine One Baylor Plaza, Texas, United States
  • Michael E Cheetham
    UCL-Institute of Ophthalmology , London, United Kingdom
  • Footnotes
    Commercial Relationships   Kelly Ziaka, None; Kwan-Leong Hau, None; Dimitra Athanasiou, None; Rosellina Guarascio, None; Mònica Aguilà, None; James Bellingham, None; Smriti A. Agrawal, None; Yumei Li, None; Rui Chen, None; Michael Cheetham, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science July 2019, Vol.60, 441. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Kelly Ziaka, Kwan-Leong Hau, Dimitra Athanasiou, Rosellina Guarascio, Mònica Aguilà, James Bellingham, Smriti A. Agrawal, Yumei Li, Rui Chen, Michael E Cheetham; Development of knock in (KI) mouse models of rhodopsin retinitis pigmentosa . Invest. Ophthalmol. Vis. Sci. 2019;60(9):441. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Inherited mutations in the light sensitive protein rhodopsin are the most common cause of autosomal dominant Retinitis Pigmentosa (RP). Rhodopsin mutations can be grouped in distinct classes based on their biochemical and cellular properties; however, many variants have not been studied in detail in vivo due to the lack of appropriate animal models. Here, we have created knock-in mice that genetically represent the M39R, T58R, R135W, and P347L mutations that are associated with dominant RP in individuals in the UK.

Methods : CRISPR/CAS9 gene editing was used for the creation of the M39R, T58R, R135W, and P347L knock in mice. Knock in production was achieved by the coinjection of Cas9 and gRNA with single stranded (ss) DNA repair template, which was designed to induce the desired genetic change, for homology directed repair (HDR). Sanger sequencing was used to identify founder mice (F0). Founders were then crossed with C57BL/6J mice. In addition, a new restriction enzyme site was created in the targeted allele for the screening of positive animals on F1 generation.

Results : We successfully created genetically altered founder mice carrying M39R, T58R, R135W, and P347L rhodopsin mutations that cause RP. After the CRISPR/Cas9 editing of the embryos, F0 animals were outcrossed with control mice and inbred to produce, both homozygous and heterozygous animals on a C57BL/6J background. Mouse colonies were successfully expanded. The gene editing showed no deleterious effects on mouse health. Experimental animals are now subject to detailed investigation of visual function and retinal morphology.

Conclusions : Generation of these new M39R, T58R, R135W, and P347L mouse models that recapitulate RP mutations at the correct gene dosage will enable the detailed investigation of the these rhodopsin variants in vivo. These new KI models will also provide insights about the disease mechanisms and facilitate future testing of potential new therapies for rhodopsin RP.

This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×